FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922456876> ?p ?o ?g. }

• W2922456876 endingPage "e548" @default.
• W2922456876 startingPage "e548" @default.
• W2922456876 abstract "To assess the long-term real-world benefit-risk profile of fingolimod in patients with relapsing MS in Germany.This analysis used data from the noninterventional real-world study, Post-Authorization Non-interventional German sAfety study of GilEnyA (PANGAEA), to assess prospectively the persistence, effectiveness, and safety of fingolimod over 36 months (±90 days) in Germany. For inclusion in the effectiveness analysis (n = 2,537), patients were required to have received fingolimod for the first time in PANGAEA, to have at least 12 months of data, and to have completed each 12-month follow-up period. For the safety analysis (n = 3,266), patients were additionally allowed to have received fingolimod before enrollment.At baseline, 94.7% of patients in the effectiveness analysis had received a previous disease-modifying therapy. After 36 months, 70.4% of patients were still receiving fingolimod. Over this period, annualized relapse rates decreased to 0.265 (95% CI: 0.244-0.286) from 1.79 (95% CI: 1.75-1.83), and mean Expanded Disability Status Scale scores remained stable (mean change from baseline: +0.049 [95% CI: -0.015 to +0.114]). In total, 16% of patients had 6-month confirmed disability improvement, 12.5% had 6-month confirmed disability worsening, and 52.4% were free from relapses and 6-month confirmed disability worsening. Adverse events (AEs) and serious AEs were experienced by up to 23.4% and 3.9% of patients, respectively, during any of the 12-month follow-up periods. The frequency and nature of AEs were in line with previous findings.Using systematically collected data from PANGAEA, this analysis demonstrates the sustained effectiveness, high persistence, and manageable safety profile of fingolimod over 36 months." @default.
• W2922456876 created "2019-03-22" @default.
• W2922456876 creator A5003043785 @default.
• W2922456876 creator A5015273008 @default.
• W2922456876 creator A5023701418 @default.
• W2922456876 creator A5028403547 @default.
• W2922456876 creator A5038006000 @default.
• W2922456876 creator A5038633707 @default.
• W2922456876 creator A5038950065 @default.
• W2922456876 creator A5044691174 @default.
• W2922456876 creator A5050112907 @default.
• W2922456876 creator A5081406086 @default.
• W2922456876 creator A5089131482 @default.
• W2922456876 date "2019-03-07" @default.
• W2922456876 modified "2023-09-26" @default.
• W2922456876 title "Real-world persistence and benefit–risk profile of fingolimod over 36 months in Germany" @default.
• W2922456876 cites W1563482990 @default.
• W2922456876 cites W1565809790 @default.
• W2922456876 cites W1986991730 @default.
• W2922456876 cites W2024600931 @default.
• W2922456876 cites W2087635386 @default.
• W2922456876 cites W2094998560 @default.
• W2922456876 cites W2104948944 @default.
• W2922456876 cites W2118735809 @default.
• W2922456876 cites W2124231203 @default.
• W2922456876 cites W2127837073 @default.
• W2922456876 cites W2145334733 @default.
• W2922456876 cites W2151340435 @default.
• W2922456876 cites W2159411766 @default.
• W2922456876 cites W2159712156 @default.
• W2922456876 cites W2171614089 @default.
• W2922456876 cites W2173315418 @default.
• W2922456876 cites W2213379694 @default.
• W2922456876 cites W2271166414 @default.
• W2922456876 cites W2274873287 @default.
• W2922456876 cites W2412766091 @default.
• W2922456876 cites W2488549833 @default.
• W2922456876 cites W2489222638 @default.
• W2922456876 cites W2538374410 @default.
• W2922456876 cites W2574090906 @default.
• W2922456876 cites W2588406503 @default.
• W2922456876 cites W2591088516 @default.
• W2922456876 cites W2609355833 @default.
• W2922456876 cites W2698539304 @default.
• W2922456876 cites W2739756297 @default.
• W2922456876 cites W2746869721 @default.
• W2922456876 cites W2779246718 @default.
• W2922456876 cites W2789428867 @default.
• W2922456876 doi "https://doi.org/10.1212/nxi.0000000000000548" @default.
• W2922456876 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6410931" @default.
• W2922456876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30882022" @default.
• W2922456876 hasPublicationYear "2019" @default.
• W2922456876 type Work @default.
• W2922456876 sameAs 2922456876 @default.
• W2922456876 citedByCount "29" @default.
• W2922456876 countsByYear W29224568762019 @default.
• W2922456876 countsByYear W29224568762020 @default.
• W2922456876 countsByYear W29224568762021 @default.
• W2922456876 countsByYear W29224568762022 @default.
• W2922456876 countsByYear W29224568762023 @default.
• W2922456876 crossrefType "journal-article" @default.
• W2922456876 hasAuthorship W2922456876A5003043785 @default.
• W2922456876 hasAuthorship W2922456876A5015273008 @default.
• W2922456876 hasAuthorship W2922456876A5023701418 @default.
• W2922456876 hasAuthorship W2922456876A5028403547 @default.
• W2922456876 hasAuthorship W2922456876A5038006000 @default.
• W2922456876 hasAuthorship W2922456876A5038633707 @default.
• W2922456876 hasAuthorship W2922456876A5038950065 @default.
• W2922456876 hasAuthorship W2922456876A5044691174 @default.
• W2922456876 hasAuthorship W2922456876A5050112907 @default.
• W2922456876 hasAuthorship W2922456876A5081406086 @default.
• W2922456876 hasAuthorship W2922456876A5089131482 @default.
• W2922456876 hasBestOaLocation W29224568761 @default.
• W2922456876 hasConcept C118552586 @default.
• W2922456876 hasConcept C126322002 @default.
• W2922456876 hasConcept C127413603 @default.
• W2922456876 hasConcept C187320778 @default.
• W2922456876 hasConcept C197934379 @default.
• W2922456876 hasConcept C2776036978 @default.
• W2922456876 hasConcept C2780640218 @default.
• W2922456876 hasConcept C2780892749 @default.
• W2922456876 hasConcept C2781009140 @default.
• W2922456876 hasConcept C3018359032 @default.
• W2922456876 hasConcept C71924100 @default.
• W2922456876 hasConceptScore W2922456876C118552586 @default.
• W2922456876 hasConceptScore W2922456876C126322002 @default.
• W2922456876 hasConceptScore W2922456876C127413603 @default.
• W2922456876 hasConceptScore W2922456876C187320778 @default.
• W2922456876 hasConceptScore W2922456876C197934379 @default.
• W2922456876 hasConceptScore W2922456876C2776036978 @default.
• W2922456876 hasConceptScore W2922456876C2780640218 @default.
• W2922456876 hasConceptScore W2922456876C2780892749 @default.
• W2922456876 hasConceptScore W2922456876C2781009140 @default.
• W2922456876 hasConceptScore W2922456876C3018359032 @default.
• W2922456876 hasConceptScore W2922456876C71924100 @default.
• W2922456876 hasIssue "3" @default.
• W2922456876 hasLocation W29224568761 @default.
• W2922456876 hasLocation W29224568762 @default.

• next